Identification of GRO1 as a critical determinant for mutant p53 gain of function.

Abstract excerpt

Mutant p53 gain of function contributes to cancer progression, increased invasion and metastasis potentials, and resistance to anticancer therapy. The ability of mutant p53 to acquire its gain of function is shown to correlate with increased expression of progrowth genes, such as c-MYC, MDR1, and NF-kappaB2. However, most of the published studies to identify mutant p53 target genes were performed in a cell system...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chemokine CXCL1
• Share to Cell Line, Tumor
• Share to Cell Proliferation